XBiotech Announces Dr. Alice Gottlieb to Chair Upcoming Phase 2 Study of Bermekimab in Hidradenitis Suppurativa

Press/Media

Period25 Jun 2019

Media coverage

1

Media coverage

  • TitleXBiotech Announces Dr. Alice Gottlieb to Chair Upcoming Phase 2 Study of Bermekimab in Hidradenitis Suppurativa
    Media name/outletThomson Reuters One
    Country/TerritoryUnited States
    Date25/06/19
    PersonsAlice Gottlieb